Suppr超能文献

按心脏诊断划分的 ICD 二级预防患者中合适和不合适治疗的时间发生率及死亡率。

Temporal Incidence of Appropriate and Inappropriate Therapy and Mortality in Secondary Prevention ICD Patients by Cardiac Diagnosis.

机构信息

Department of Cardiology, Herlev-Gentofte University Hospital, Hellerup, Denmark.

Department of Cardiology, Herlev-Gentofte University Hospital, Hellerup, Denmark; Department of Cardiology, Zealand University Hospital, Roskilde, Denmark.

出版信息

JACC Clin Electrophysiol. 2021 Jun;7(6):781-792. doi: 10.1016/j.jacep.2020.11.005. Epub 2021 Jan 27.

Abstract

OBJECTIVES

This study sought to estimate the temporal development in rates and incidences of appropriate and inappropriate implantable cardioverter-defibrillator (ICD) therapy and shocks by cardiac diagnosis in a real-world population of patients with secondary prevention ICDs.

BACKGROUND

Data on cardiac diagnoses and temporal development of ICD therapies in patients with secondary prevention ICDs are limited.

METHODS

Patients (N = 4,587) with a secondary prevention ICD were identified from the Danish Pacemaker and ICD Register (January 1, 2007, to December 31, 2016) and linked to nationwide administrative registers. The outcome of appropriate and inappropriate ICD therapy and all-cause mortality were analyzed by annual event rates, cumulative incidence plots, and Cox regression models.

RESULTS

During a mean follow-up of 3.6 ± 2.4 years, 1,362 patients (30%) experienced appropriate ICD therapy (16.8% shocks), and 350 patients (7.6%) experienced inappropriate ICD therapy (4.6% shocks). From 2007 to 2016, there was a significant temporal reduction in both appropriate and inappropriate ICD therapy from 28.2 (95% confidence interval [CI]: 21.6 to 37.0) to 7.9 (95% CI: 6.8 to 9.1) and 10.0 (95% CI: 6.4 to 15.5) to 1.0 (95% CI: 0.7 to 1.5) per 100 person-years (p for trends <0.001). Multivariate Cox regression analyses showed that arrhythmogenic right ventricular cardiomyopathy was associated with the highest probability of appropriate ICD therapy (hazard ratio: 2.45; 95% CI: 1.77 to 3.39; p < 0.0001), whereas patients with hypertrophic cardiomyopathy had the lowest probability (hazard ratio: 0.62; 95% CI: 0.42 to 0.93; p = 0.0196) when compared to patients with ischemic heart disease.

CONCLUSIONS

In this nationwide real-life cohort of patients with secondary prevention ICDs, we observed a significant temporal decline in delivered appropriate and inappropriate shocks and ICD therapies in the last decade. A large proportion of patients still experienced ICD therapy but with significant differences by cardiac diagnosis.

摘要

目的

本研究旨在评估在具有二级预防 ICD 的真实人群中,根据心脏诊断,适当和不适当的植入式心律转复除颤器(ICD)治疗和电击的发生率和发病率的时间发展情况。

背景

关于具有二级预防 ICD 的患者的心脏诊断和 ICD 治疗的时间发展的数据有限。

方法

从丹麦起搏器和 ICD 登记处(2007 年 1 月 1 日至 2016 年 12 月 31 日)中确定了 4587 名具有二级预防 ICD 的患者,并与全国性行政登记处相关联。通过年度事件率、累积发病率图和 Cox 回归模型分析适当和不适当的 ICD 治疗以及全因死亡率。

结果

在平均 3.6±2.4 年的随访期间,1362 名患者(30%)经历了适当的 ICD 治疗(16.8%为电击),350 名患者(7.6%)经历了不适当的 ICD 治疗(4.6%为电击)。从 2007 年到 2016 年,适当和不适当的 ICD 治疗的时间均显著减少,从 28.2(95%置信区间[CI]:21.6 至 37.0)降至 7.9(95%CI:6.8 至 9.1)和 10.0(95%CI:6.4 至 15.5)至 1.0(95%CI:0.7 至 1.5)每 100 人年(趋势 P<0.001)。多变量 Cox 回归分析表明,致心律失常性右心室心肌病与适当的 ICD 治疗的可能性最高相关(风险比:2.45;95%CI:1.77 至 3.39;P<0.0001),而肥厚型心肌病患者的可能性最低(风险比:0.62;95%CI:0.42 至 0.93;P=0.0196)与缺血性心脏病患者相比。

结论

在这项具有二级预防 ICD 的全国性真实队列研究中,我们观察到过去十年中适当和不适当电击和 ICD 治疗的时间明显下降。尽管仍有很大一部分患者接受了 ICD 治疗,但心脏诊断之间存在显著差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验